Exploring Predictors of Response to Dacomitinib in EGFR-Amplified Recurrent Glioblastoma
2020
PURPOSEDespite the high frequency of EGFR genetic alterations in glioblastoma (GBM), EGFR-targeted therapies have not had success in this disease. To improve the likelihood of efficacy, we targeted...
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
53
References
5
Citations
NaN
KQI